{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:34:06Z","timestamp":1793273646980,"version":"4.5.0"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Robert & Heather Urich Research"},{"name":"Patient Care Endowment Fund at the University of Michigan"},{"name":"Walther Cancer Institute, Indianapolis, IN"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chordomas are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. These tumors typically occur in the axial skeleton and have a proclivity for the spheno-occipital region of the skull base and sacral regions. In adults, 50% of chordomas involve the sacrococcygeal region, 35% occur at the base of the skull near the spheno-occipital area, and 15% are found in the vertebral column. Craniocervical chordomas most often involve the dorsum sella, clivus, and nasopharynx. Chordomas are divided into conventional, chondroid, and dedifferentiated types. Conventional chordomas are the most common. They are characterized by the absence of cartilaginous or additional mesenchymal components. Chondroid chordomas contain both chordomatous and chondromatous features, and have a predilection for the spheno-occipital region of the skull base. This variant accounts for 5%\u201315% of all chordomas and up to 33% of cranial chordomas. Dedifferentiation or sarcomatous transformation occurs in 2%\u20138% of chordomas. This can develop at the onset of the disease or later. Aggressive initial therapy improves overall outcome. Patients who relapse locally have a poor prognosis but both radiation and surgery can be used as salvage therapy. Subtotal resection can result in a stable or improved status in as many as 50% of patients who relapse after primary therapy. Radiation therapy may also salvage some patients with local recurrence. One series reported a 2-year actuarial local control rate of 33% for patients treated with proton beam irradiation.<\/jats:p>","DOI":"10.1634\/theoncologist.12-11-1344","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T14:39:01Z","timestamp":1196433541000},"page":"1344-1350","source":"Crossref","is-referenced-by-count":314,"title":["Chordoma: The Nonsarcoma Primary Bone Tumor"],"prefix":"10.1093","volume":"12","author":[{"given":"Rashmi","family":"Chugh","sequence":"first","affiliation":[{"name":"a Department of Internal Medicine, Division of Hematology\/Oncology, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Tawbi","sequence":"additional","affiliation":[{"name":"d Department of Medicine, Division of Hematology\/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lucas","sequence":"additional","affiliation":[{"name":"b Department of, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Sybil","family":"Biermann","sequence":"additional","affiliation":[{"name":"c Department of Orthopedic Surgery, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Schuetze","sequence":"additional","affiliation":[{"name":"a Department of Internal Medicine, Division of Hematology\/Oncology, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence H.","family":"Baker","sequence":"additional","affiliation":[{"name":"a Department of Internal Medicine, Division of Hematology\/Oncology, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2021122208425838500_R1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2021122208425838500_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008947301735","article-title":"Chordoma: Incidence and survival patterns in the United States, 1973\u20131995","volume":"12","author":"McMaster","year":"2001","journal-title":"Cancer Causes Control"},{"key":"2021122208425838500_R3","first-page":"316","volume-title":"Pathology and Genetics of Tumours of Soft Tissue and Bone","author":"Mirra","year":"2002"},{"key":"2021122208425838500_R4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cancergencyto.2006.06.007","article-title":"Clonality studies in sacral chordoma","volume":"171","author":"Klingler","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122208425838500_R5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1245\/ASO.2003.06.002","article-title":"Chordoma: Natural history and results in 28 patients treated at a single institution","volume":"10","author":"Baratti","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"2021122208425838500_R6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ajcp\/53.4.544","article-title":"The ultrastructure of chordoma","volume":"53","author":"Pena","year":"1970","journal-title":"Am J Clin Pathol"},{"key":"2021122208425838500_R7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1097-0142(196711)20:11<1841::AID-CNCR2820201107>3.0.CO;2-2","article-title":"Chordoma. Thirty-five-year study at Memorial Hospital","volume":"20","author":"Higinbotham","year":"1967","journal-title":"Cancer"},{"key":"2021122208425838500_R8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0167-8140(96)91805-8","article-title":"Chordoma: Long-term follow-up after radical photon irradiation","volume":"41","author":"Catton","year":"1996","journal-title":"Radiother Oncol"},{"key":"2021122208425838500_R9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ajcp\/72.5.765","article-title":"Chordoma. A clinicopathologic study of metastasis","volume":"72","author":"Chambers","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"2021122208425838500_R10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/CCO.0b013e3281214448","article-title":"Chordoma","volume":"19","author":"Casali","year":"2007","journal-title":"Current Opin Oncol"},{"key":"2021122208425838500_R11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ijc.11421","article-title":"Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis","volume":"107","author":"Riva","year":"2003","journal-title":"Int J Cancer"},{"key":"2021122208425838500_R12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9098(200002)73:2<100::AID-JSO8>3.0.CO;2-M","article-title":"Microsatellite instability in sacral chordoma","volume":"73","author":"Klingler","year":"2000","journal-title":"J Surg Oncol"},{"key":"2021122208425838500_R13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-4608(94)90210-0","article-title":"Cytogenetic and molecular cytogenetic analysis of sacral chordoma","volume":"75","author":"Bridge","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122208425838500_R14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(03)00002-5","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Chondrosarcoma and other cartilaginous neoplasms","volume":"143","author":"Sandberg","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122208425838500_R15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0090-3019(96)00432-6","article-title":"Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas","volume":"47","author":"Eisenberg","year":"1997","journal-title":"Surg Neurol"},{"key":"2021122208425838500_R16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0165-4608(95)00142-5","article-title":"Chromosome telomere integrity of human solid neoplasms","volume":"86","author":"Butler","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122208425838500_R17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-4608(95)00127-1","article-title":"Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas","volume":"85","author":"Butler","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122208425838500_R18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.brs.0000200038.30869.27","article-title":"Chordoma of the mobile spine: Fifty years of experience","volume":"31","author":"Boriani","year":"2006","journal-title":"Spine"},{"key":"2021122208425838500_R19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1227\/01.NEU.0000223441.51012.9D","article-title":"Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas","volume":"59","author":"Tzortzidis","year":"2006","journal-title":"Neurosurgery"},{"key":"2021122208425838500_R20","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1","article-title":"Prognostic factors in chordoma of the sacrum and mobile spine: A study of 39 patients","volume":"88","author":"Bergh","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"2021122208425838500_R21","first-page":"284","article-title":"En bloc removal of the lower lumbar vertebral body for chordoma. Report of two cases","volume":"94","author":"Bosma","year":"2001","journal-title":"J Neurosurg"},{"key":"2021122208425838500_R22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02221451","article-title":"A lumbar chordoma treated with a wide resection","volume":"3","author":"Bas","year":"1994","journal-title":"Eur Spine J"},{"key":"2021122208425838500_R23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0090-3019(98)00078-0","article-title":"\u201cEn-bloc\u201d vertebrectomy in the mobile lumbar spine","volume":"50","author":"Heary","year":"1998","journal-title":"Surg Neurol"},{"key":"2021122208425838500_R24","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1097\/00007632-200010010-00018","article-title":"Follow-up evaluation of resected lumbar vertebral chordoma over 11 years: A case report","volume":"25","author":"Hsu","year":"2000","journal-title":"Spine"},{"key":"2021122208425838500_R25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3171\/jns.1996.85.3.0438","article-title":"Indications and results of combined anterior-posterior approaches for spine tumor surgery","volume":"85","author":"Sundaresan","year":"1996","journal-title":"J Neurosurg"},{"key":"2021122208425838500_R26","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/00007632-199909010-00016","article-title":"Chordoma in the cervical spine managed with en bloc excision","volume":"24","author":"Fujita","year":"1999","journal-title":"Spine"},{"key":"2021122208425838500_R27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00007632-198310000-00016","article-title":"Intrathoracic chordoma presenting as a posterior superior mediastinal tumor","volume":"8","author":"Cotler","year":"1983","journal-title":"Spine"},{"key":"2021122208425838500_R28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3171\/jns.1991.75.3.0374","article-title":"Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution","volume":"75","author":"Keisch","year":"1991","journal-title":"J Neurosurg"},{"key":"2021122208425838500_R29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/1097-0142(19850701)56:1<182::AID-CNCR2820560131>3.0.CO;2-J","article-title":"Clinical and pathologic review of 48 cases of chordoma","volume":"56","author":"Rich","year":"1985","journal-title":"Cancer"},{"key":"2021122208425838500_R30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF00607279","article-title":"An unusual cervical chordoma: CT and MRI","volume":"38","author":"Anegawa","year":"1996","journal-title":"Neuroradiology"},{"key":"2021122208425838500_R31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s003300050611","article-title":"CT and MRI appearances of a thoracic chordoma","volume":"8","author":"Murphy","year":"1998","journal-title":"Eur Radiol"},{"key":"2021122208425838500_R32","first-page":"267","article-title":"Imaging of chordomas of the mobile spine","volume":"18","author":"Ducou le Pointe","year":"1991","journal-title":"J Neuroradiol"},{"key":"2021122208425838500_R33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00256-003-0633-1","article-title":"Value of MRI in the diagnosis of non-clival, non-sacral chordoma","volume":"32","author":"Smolders","year":"2003","journal-title":"Skeletal Radiol"},{"key":"2021122208425838500_R34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1227\/01.NEU.0000114263.01917.1E","article-title":"Intensity-modulated stereotactic radiotherapy of paraspinal tumors: A preliminary report","volume":"54","author":"Bilsky","year":"2004","journal-title":"Neurosurgery"},{"key":"2021122208425838500_R35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00066-003-1065-5","article-title":"Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure","volume":"179","author":"Noel","year":"2003","journal-title":"Strahlenther Onkol"},{"key":"2021122208425838500_R36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1097-0142(19930201)71:3<735::AID-CNCR2820710314>3.0.CO;2-8","article-title":"Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients","volume":"71","author":"Bjornsson","year":"1993","journal-title":"Cancer"},{"key":"2021122208425838500_R37","first-page":"87","article-title":"Chordoma: Long-term evaluation of 15 cases treated surgically","volume":"83","author":"Logroscino","year":"1998","journal-title":"Chir Organi Mov"},{"key":"2021122208425838500_R38","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2006.02.059","article-title":"Sacral chordomas: Impact of high-dose proton\/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor","volume":"65","author":"Park","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jso.20477","article-title":"Level-adjusted perioperative risk of sacral amputations","volume":"94","author":"Devin","year":"2006","journal-title":"J Surg Oncol"},{"key":"2021122208425838500_R40","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/00007632-199908150-00004","article-title":"Lumbosacral chordoma. Prognostic factors and treatment","volume":"24","author":"Cheng","year":"1999","journal-title":"Spine"},{"key":"2021122208425838500_R41","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0360-3016(89)90969-3","article-title":"Neurovisual outcome following proton radiation therapy","volume":"16","author":"Habrand","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0360-3016(97)00364-7","article-title":"Brainstem tolerance to conformal radiotherapy of skull base tumors","volume":"39","author":"Debus","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0360-3016(00)01387-0","article-title":"Hypothalamic\/pituitary function following high-dose conformal radiotherapy to the base of skull: Demonstration of a dose-effect relationship using dose-volume histogram analysis","volume":"49","author":"Pai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0360-3016(88)90301-X","article-title":"Endocrine function following high dose proton therapy for tumors of the upper clivus","volume":"15","author":"Slater","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0360-3016(83)90228-6","article-title":"Chordoma: The results of megavoltage radiation therapy","volume":"9","author":"Cummings","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3171\/jns.1989.70.1.0013","article-title":"Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull","volume":"70","author":"Austin-Seymour","year":"1989","journal-title":"J Neurosurg"},{"key":"2021122208425838500_R47","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2004.05.064","article-title":"Clinical results of proton beam therapy for skull base chordoma","volume":"60","author":"Igaki","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R48","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/02841860500326257","article-title":"Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams","volume":"44","author":"Noel","year":"2005","journal-title":"Acta Oncol"},{"key":"2021122208425838500_R49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijrobp.2003.09.041","article-title":"Results of carbon ion radiotherapy in 152 patients","volume":"58","author":"Schulz-Ertner","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0360-3016(99)00146-7","article-title":"Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma","volume":"45","author":"Terahara","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijrobp.2005.02.023","article-title":"Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The Paul Scherrer Institut experience","volume":"63","author":"Weber","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R52","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/1097-0142(19950201)75:3<749::AID-CNCR2820750302>3.0.CO;2-D","article-title":"Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques","volume":"75","author":"Tai","year":"1995","journal-title":"Cancer"},{"issue":"suppl 2","key":"2021122208425838500_R53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03038890","article-title":"Proton therapy for tumors of the skull base","volume":"175","author":"Munzenrider","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"2021122208425838500_R54","first-page":"80","article-title":"Management issues in chordoma: A case series","volume":"12","author":"Tai","year":"2000","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122208425838500_R55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3171\/jns.2001.95.2.0184","article-title":"A multidisciplinary team approach to skull base chondrosarcomas","volume":"95","author":"Crockard","year":"2001","journal-title":"J Neurosurg"},{"key":"2021122208425838500_R56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00066-003-1052-x","article-title":"A small prospective study of chordomas treated with radiotherapy and razoxane","volume":"179","author":"Rhomberg","year":"2003","journal-title":"Strahlenther Onkol"},{"key":"2021122208425838500_R57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006123-199602000-00044","article-title":"Chordomas and chondrosarcomas of the cranial base: Results and follow-up of 60 patients","volume":"38","author":"Crockard","year":"1996","journal-title":"Neurosurgery"},{"key":"2021122208425838500_R58","first-page":"S28","article-title":"Conformal versus IMRT for chordoma of the skull base and cervical spine","volume":"19","author":"Foweraker","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122208425838500_R59","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3171\/jns.1999.91.3.0432","article-title":"Proton radiation therapy for chordomas and chondrosarcomas of the skull base","volume":"91","author":"Hug","year":"1999","journal-title":"J Neurosurg"},{"key":"2021122208425838500_R60","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0360-3016(01)01634-0","article-title":"Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: The Centre de Protontherapie D'Orsay experience","volume":"51","author":"Noel","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0360-3016(94)90550-9","article-title":"Experience in charged particle irradiation of tumors of the skull base: 1977\u20131992","volume":"29","author":"Castro","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0360-3016(93)90209-E","article-title":"Charged particle irradiation of sacral chordomas","volume":"26","author":"Schoenthaler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0360-3016(88)90295-7","article-title":"Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: The Lawrence Berkeley Laboratory experience","volume":"15","author":"Berson","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425838500_R64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-0142(19930801)72:3<714::AID-CNCR2820720314>3.0.CO;2-1","article-title":"Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases","volume":"72","author":"Fleming","year":"1993","journal-title":"Cancer"},{"key":"2021122208425838500_R65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00043426-199605000-00032","article-title":"Chemotherapeutic treatment of malignant chordoma in children","volume":"18","author":"Scimeca","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122208425838500_R66","first-page":"274","article-title":"Chordoma of the cervical spine treated with vincristine sulfate","volume":"5","author":"Razis","year":"1974","journal-title":"J Med"},{"key":"2021122208425838500_R67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archsurg.1959.04320070156027","article-title":"Metastatic chordoma use of mechlorethamine (nitrogen mustard) in chordoma therapy","volume":"79","author":"McSweeney","year":"1959","journal-title":"AMA Arch Surg"},{"key":"2021122208425838500_R68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jso.2930370311","article-title":"Chordoma: Natural history and treatment results in 33 cases","volume":"37","author":"Azzarelli","year":"1988","journal-title":"J Surg Oncol"},{"key":"2021122208425838500_R69","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1200\/JCO.2005.02.170","article-title":"Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma","volume":"23","author":"Chugh","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122208425838500_R70","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.20618","article-title":"Imatinib mesylate in chordoma","volume":"101","author":"Casali","year":"2004","journal-title":"Cancer"},{"issue":"18","key":"2021122208425838500_R71","article-title":"Imatinib mesylate in advanced chordoma: A multicenter phase II study","volume":"25","author":"Stacchiotti","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122208425838500_R72","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1158\/1078-0432.CCR-06-1584","article-title":"Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas","volume":"12","author":"Tamborini","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2021122208425838500_R73","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4161\/cbt.4.11.2253","article-title":"Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes","volume":"4","author":"Burger","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"18","key":"2021122208425838500_R74","article-title":"Adding cisplatin (CDDP) to imatinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma","volume":"25","author":"Casali","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122208425838500_R75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archotol.131.8.707","article-title":"Differential expression of epidermal growth factor receptor, c-Met, and HER2\/neu in chordoma compared with 17 other malignancies","volume":"131","author":"Weinberger","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2021122208425838500_R76","first-page":"572","article-title":"Effectiveness of cetuximab\/gefitinib in the therapy of a sacral chordoma","volume":"29","author":"Hof","year":"2006","journal-title":"Onkologie"},{"key":"2021122208425838500_R77","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00001813-200511000-00015","article-title":"Recurrent and metastatic clivus chordoma: Systemic palliative therapy retards disease progression","volume":"16","author":"Schonegger","year":"2005","journal-title":"Anticancer Drugs"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.12-11-1344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.12-11-1344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/12\/11\/1344\/41835924\/oncolo_12_11_1344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/12\/11\/1344\/41835924\/oncolo_12_11_1344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T10:13:00Z","timestamp":1640167980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/12\/11\/1344\/6396640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.12-11-1344","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,11,1]]},"published":{"date-parts":[[2007,11,1]]}}}